pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Misoprostol Greenstone
drug · small molecule
save

misoprostol

Phase 2updated 6mo ago
by AFYX Therapeutics A/S🔗 ChEMBL
Phase 2
community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 27 investigational indications.

targets

Prostaglandin E2 receptor EP3 subtype

all catalysts(0)

nothing on the calendar yet

Trials studying misoprostol

  • —Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortionterminatedn=129
  • phase4A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour Inductioncompletedn=520
  • N/AComparative Study Between Preoperative and Postoperative Rectal Misoprostolcompletedn=128
  • phase4Comparison of Misoprostol Ripening Efficacy With Dilapancompletedn=307

News(10)

  • FDA finalizes cell and gene therapy potency guidance
    In a final guidance issued on Monday, the US Food and Drug Administration (FDA) laid out its expectations for cell and gene therapy (CGT) sponsors to demonstrate that their products meet potency st…
    raps · 15d ago
  • Mifepristone study highlights need for more transparency, data collection in FDA’s REMS program
    Patients who reviewed and signed a patient agreement form (PAF) for mifepristone and misoprostol under the US Food and Drug Administration’s (FDA) risk evaluation and mitigation strategy (REMS) pro…
    raps · 15d ago
  • FDA says its safety review of abortion pill will continue into next year
    The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents.
    stat · 1mo ago
  • Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
    “With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.
    stat · 1mo ago
  • Opinion: The new geography of abortion care
    Even before Dobbs, patients had “begun reorganizing abortion care outside traditional health care settings,” writes Jennifer Karlin.
    stat · 3mo ago
  • Opinion: Telehealth abortion with mifepristone continues, with backup plans still in place
    Restricting telehealth prescribing of mifepristone wouldn't spell the end of telehealth medication abortion, writes OB-GYN Christine Henneberg.
    stat · 6mo ago
  • Supreme Court preserves access to widely used abortion pill, while lawsuit plays out
    The Supreme Court on Thursday preserved women’s access to the abortion drug mifepristone, rejecting lower-court restrictions while a lawsuit continues.
    stat · 6mo ago
  • Supreme Court temporarily extends women’s access to a widely used abortion pill
    The Supreme Court is temporarily extending access to a widely used abortion pill while it considers whether to allow restrictions on the drug to take effect.
    stat · 6mo ago
  • Former FDA leaders, pharma speak out on mifepristone
    “The fundamental question is: Who gets to regulate mifepristone?”
    stat · 6mo ago
  • Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies
    The Supreme Court on Monday restored broad access to the abortion pill mifepristone, blocking a ruling that had threatened to upend one of the main ways abortion is provided across the…
    stat · 6mo ago
view all news mentions →
brand
Misoprostol Greenstone
trade names
Cytotec, Misoprostol, Misoprostol component of arthrotec, Mysodelle, Topogyne
generic
misoprostol
MOA
Prostanoid EP3 receptor agonist
indication
Labor And Delivery
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 5h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?